EP 3484348 A4 20211124 - METHOD AND SYSTEM FOR MICROBIAL PHARMACOGENOMICS
Title (en)
METHOD AND SYSTEM FOR MICROBIAL PHARMACOGENOMICS
Title (de)
VERFAHREN UND SYSTEM FÜR MIKROBIELLE PHARMAKOGENOMIK
Title (fr)
PROCÉDÉ ET SYSTÈME DE PHARMACOGÉNOMIQUE MICROBIENNE
Publication
Application
Priority
- US 201662361943 P 20160713
- US 201715606743 A 20170526
- US 2017042015 W 20170713
Abstract (en)
[origin: WO2018013865A1] Embodiments of a method and system for microbial pharmacogenomics can include: a sample handling system operable to collect containers including biological samples from a set of users, the handling system including a sequencing system operable to determine microorganism sequences from the biological samples; a microbiome characterization system operable to: determine microbiome pharmacogenomics data based on the microorganism sequences, collect supplementary data associated with the antibiotics- associated condition for the set of users, and transform the supplementary data and features extracted from the microbiome pharmacogenomics data into a characterization model associated with the antibiotics-associated condition; and a treatment system operable to promote a treatment to the user for the antibiotics-associated condition based on characterizing user biological material with the characterization model in relation to the antibiotics-associated condition.
IPC 8 full level
G01N 33/50 (2006.01); A61B 1/00 (2006.01); A61B 5/00 (2006.01); A61B 5/05 (2021.01); C12Q 1/04 (2006.01); C12Q 1/689 (2018.01); G16B 20/00 (2019.01); G16B 40/10 (2019.01); G16B 40/20 (2019.01); G16H 50/20 (2018.01)
CPC (source: EP KR)
A61B 5/4839 (2013.01 - EP KR); A61B 5/4848 (2013.01 - EP KR); A61B 5/746 (2013.01 - KR); A61B 5/7465 (2013.01 - KR); C12Q 1/689 (2013.01 - EP KR); G16B 20/00 (2019.01 - EP); G16B 40/20 (2019.01 - EP); A61B 5/746 (2013.01 - EP); A61B 5/7465 (2013.01 - EP); C12Q 2600/106 (2013.01 - EP KR); C12Q 2600/156 (2013.01 - EP KR); G16H 20/13 (2017.12 - EP); G16H 40/63 (2017.12 - EP); G16H 50/20 (2017.12 - EP); G16H 50/30 (2017.12 - EP); G16H 50/50 (2017.12 - EP); G16H 50/70 (2017.12 - EP); Y02A 90/10 (2017.12 - EP)
Citation (search report)
- [XY] US 2016110515 A1 20160421 - APTE ZACHARY [US], et al
- [Y] WO 2016086305 A1 20160609 - UNIV SASKATCHEWAN [CA]
- [IY] WO 2015066625 A1 20150507 - UNIV WASHINGTON [US]
- See references of WO 2018013865A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2018013865 A1 20180118; AU 2017295861 A1 20190124; BR 112019000709 A2 20190514; BR 112019000709 A8 20230321; CA 3030792 A1 20180118; CN 109475305 A 20190315; CN 109475305 B 20220125; CO 2019001319 A2 20190219; EA 201990294 A1 20190830; EP 3484348 A1 20190522; EP 3484348 A4 20211124; JP 2019521706 A 20190808; JP 2022079646 A 20220526; KR 102397683 B1 20220513; KR 20190033561 A 20190329; SG 11201900253T A 20190227; ZA 201900473 B 20190925
DOCDB simple family (application)
US 2017042015 W 20170713; AU 2017295861 A 20170713; BR 112019000709 A 20170713; CA 3030792 A 20170713; CN 201780043788 A 20170713; CO 2019001319 A 20190213; EA 201990294 A 20170713; EP 17828501 A 20170713; JP 2019522621 A 20170713; JP 2022058908 A 20220331; KR 20197004007 A 20170713; SG 11201900253T A 20170713; ZA 201900473 A 20190123